Skip to main content
2024 DC-CSEM Conference Main banner
On-Demand

Clinical Coversations

CC04 - DKD - Beyond traditional management of T2D

Friday, November 22, 2024
17:20 - 17:40 AT Time
Location: Clinical Conversations Theater 2

    Speaker(s)

  • AJ

    Akshay Jain, MD

    Endocrinologist
    University of British Columbia
    University of British Columbia
    Surrey, British Columbia, Canada

    Disclosure information not submitted.

  • Lori Berard, n/a (she/her/hers)

    Nurse Consultant
    Independent
    Winnipeg, Manitoba, Canada

    Disclosure(s): Abbott Diabetes: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly Canada: Speaker/Honoraria (Ongoing); EMBECTA: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); MontMed: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk A/S: Consultant (Ongoing)

Topic: DKD - Beyond traditional management of T2D

This is an unaccredited activity sponsored by Bayer Inc. This activity is not part of the 2024 Diabetes Canada/CSEM accredited educational programming as planned by the Diabetes Canada/CSEM Scientific Planning Committee and does not qualify for Maintenance of Certification credits.

Learning Objectives:

  • Understand the relationship between albuminuria (UACR) and cardiorenal risk and the importance of early testing
  • Review current treatment strategies to address residual risk with a focus on ns-MRAs as a targeted option
  • Integrate the Diabetes Canada 2024 Kidney protection guidelines through case based discussion